ArticleCureus2025
Biogenic Fabrication of Nanoparticles With Rhododendron arboreum: A Multifunctional Platform With Antibacterial, Anti-inflammatory, and Anticancer Therapeutic Potential.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- BiogenicRSC advances · 2026Article
- Advancements of mRNA-lipid nanoparticle links to gene editing and immune responses.Journal, genetic engineering & biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlant-mediated nanotechnology offers a sustainable alternative to conventional nanoparticle synthesis by reducing reliance on hazardous chemicals and energy-intensive processes. Zinc sulfide nanoparticles (ZnS NPs) were selected for this study due to their wide bandgap, tunable optical properties, and promising biomedical potential compared to other semiconductor nanoparticles.
methodsZnS NPs were synthesized via a Soxhlet extract-assisted method and characterized using Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, and UV-visible spectroscopy.
resultsThe nanoparticles exhibited a cubic phase structure with a crystallite size of 2.28 nm, an optical bandgap of 2.8 eV, and peak absorption at 356 nm. SEM analysis revealed irregular morphology. Biological assays demonstrated that the ZnS NPs possessed superior antibacterial activity compared to the flower extract alone, with lower minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values against
conclusionsThese findings highlight how green synthesis using
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.